Michael Mix

8PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyInstruments and techniquesPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 21, 2026
Multimodal PET-MR segmentation for glioblastoma: complementarity for treatment planning and recurrence definition.

|Nov 27, 2021
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial.

Constantinos Zamboglou, Simon K B Spohn, Sonja Adebahr

|Jul 24, 2021
18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy.

Montserrat Carles, Tobias Fechter, Anca L Grosu

|Mar 06, 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy.

Montserrat Carles, Tobias Fechter, Gianluca Radicioni

|Mar 04, 2021
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle.

Michael Mix, Wolfgang Schultze-Seemann, Moritz von Büren

|Nov 18, 2020
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial.

Eleni Gkika, Stefan Lenz, Tanja Schimek-Jasch

Pageof 2

Frequent Collaborators

4 joint publications

Dimos Baltas

3 joint publications

Luis Martí-Bonmatí

3 joint publications

Tobias Fechter

3 joint publications

Montserrat Carles